224 related articles for article (PubMed ID: 34664412)
1. Dexmedetomidine alleviates hepatic ischaemia-reperfusion injury via the PI3K/AKT/Nrf2-NLRP3 pathway.
Wu Y; Qiu G; Zhang H; Zhu L; Cheng G; Wang Y; Li Y; Wu W
J Cell Mol Med; 2021 Nov; 25(21):9983-9994. PubMed ID: 34664412
[TBL] [Abstract][Full Text] [Related]
2. Dexmedetomidine abates myocardial ischemia reperfusion injury through inhibition of pyroptosis via regulation of miR-665/MEF2D/Nrf2 axis.
Wang L; Liu J; Wang Z; Qian X; Zhao Y; Wang Q; Dai N; Xie Y; Zeng W; Yang W; Bai X; Yang Y; Qian J
Biomed Pharmacother; 2023 Sep; 165():115255. PubMed ID: 37549462
[TBL] [Abstract][Full Text] [Related]
3. Dexmedetomidine attenuates renal ischemia-reperfusion injury through activating PI3K/Akt-eNOS signaling via α
Shan X; Zhang J; Wei X; Tao W; Peng K; Liu H; Wang Y; Liu H; Meng X; Ji F
FASEB J; 2022 Nov; 36(11):e22608. PubMed ID: 36250975
[TBL] [Abstract][Full Text] [Related]
4. Dexmedetomidine exerts cerebral protective effects against cerebral ischemic injury by promoting the polarization of M2 microglia via the Nrf2/HO-1/NLRP3 pathway.
Wang N; Nie H; Zhang Y; Han H; Wang S; Liu W; Tian K
Inflamm Res; 2022 Jan; 71(1):93-106. PubMed ID: 34767031
[TBL] [Abstract][Full Text] [Related]
5. Dexmedetomidine alleviates hepatic injury via the inhibition of oxidative stress and activation of the Nrf2/HO-1 signaling pathway.
Zhao Y; Kong GY; Pei WM; Zhou B; Zhang QQ; Pan BB
Eur Cytokine Netw; 2019 Sep; 30(3):88-97. PubMed ID: 31957703
[TBL] [Abstract][Full Text] [Related]
6. Dexmedetomidine alleviates lung ischemia-reperfusion injury in rats by activating PI3K/Akt pathway.
Liang S; Wang Y; Liu Y
Eur Rev Med Pharmacol Sci; 2019 Jan; 23(1):370-377. PubMed ID: 30657579
[TBL] [Abstract][Full Text] [Related]
7. Dexmedetomidine Ameliorates Post-CPB Lung Injury in Rats by Activating the PI3K/Akt Pathway.
Li J; Dou X; Li D; He M; Han M; Zhang H
J Invest Surg; 2020 Jul; 33(6):576-583. PubMed ID: 30913929
[No Abstract] [Full Text] [Related]
8. Dexmedetomidine Ameliorates Hippocampus Injury and Cognitive Dysfunction Induced by Hepatic Ischemia/Reperfusion by Activating SIRT3-Mediated Mitophagy and Inhibiting Activation of the NLRP3 Inflammasome in Young Rats.
Yu W; Lyu J; Jia L; Sheng M; Yu H; Du H
Oxid Med Cell Longev; 2020; 2020():7385458. PubMed ID: 34493950
[TBL] [Abstract][Full Text] [Related]
9. Dexmedetomidine protects mice against myocardium ischaemic/reperfusion injury by activating an AMPK/PI3K/Akt/eNOS pathway.
Sun Y; Jiang C; Jiang J; Qiu L
Clin Exp Pharmacol Physiol; 2017 Sep; 44(9):946-953. PubMed ID: 28556946
[TBL] [Abstract][Full Text] [Related]
10. Dexmedetomidine inhibits pyroptosis by down-regulating miR-29b in myocardial ischemia reperfusion injury in rats.
Zhong Y; Li YP; Yin YQ; Hu BL; Gao H
Int Immunopharmacol; 2020 Sep; 86():106768. PubMed ID: 32679539
[TBL] [Abstract][Full Text] [Related]
11. Dexmedetomidine improves propofol-induced neuronal injury in rat hippocampus with the involvement of miR-34a and the PI3K/Akt signaling pathway.
Xing N; Xing F; Li Y; Li P; Zhang J; Wang D; Zhang W; Yang J
Life Sci; 2020 Apr; 247():117359. PubMed ID: 32001264
[TBL] [Abstract][Full Text] [Related]
12. Dexmedetomidine Alleviates Brain Ischemia/Reperfusion Injury by Regulating Metastasis-associated Lung Adenocarcinoma Transcript 1/MicroRNA-140-5p/ Nuclear Factor Erythroid-derived 2-like 2 Axis.
Qin Z; Xu Y
Protein Pept Lett; 2024; 31(2):116-127. PubMed ID: 38083898
[TBL] [Abstract][Full Text] [Related]
13. DHA attenuates hepatic ischemia reperfusion injury by inhibiting pyroptosis and activating PI3K/Akt pathway.
Li Z; Zhao F; Cao Y; Zhang J; Shi P; Sun X; Zhang F; Tong L
Eur J Pharmacol; 2018 Sep; 835():1-10. PubMed ID: 30075219
[TBL] [Abstract][Full Text] [Related]
14. Pectolinarigenin attenuates hepatic ischemia/reperfusion injury via activation of the PI3K/AKT/Nrf2 signaling pathway.
Li H; Chen Y; Ding M; Yan Z; Guo W; Guo R
Chem Biol Interact; 2023 Dec; 386():110763. PubMed ID: 37832626
[TBL] [Abstract][Full Text] [Related]
15. Effects of dexmedetomidine postconditioning on myocardial ischemia and the role of the PI3K/Akt-dependent signaling pathway in reperfusion injury.
Cheng XY; Gu XY; Gao Q; Zong QF; Li XH; Zhang Y
Mol Med Rep; 2016 Jul; 14(1):797-803. PubMed ID: 27221008
[TBL] [Abstract][Full Text] [Related]
16. Dexmedetomidine pretreatment protects the heart against apoptosis in ischemia/reperfusion injury in diabetic rats by activating PI3K/Akt signaling in vivo and in vitro.
Chang JH; Jin MM; Liu JT
Biomed Pharmacother; 2020 Jul; 127():110188. PubMed ID: 32407987
[TBL] [Abstract][Full Text] [Related]
17. Dexmedetomidine protects H9C2 against hypoxia/reoxygenation injury through miR-208b-3p/Med13/Wnt signaling pathway axis.
Wang Z; Yang Y; Xiong W; Zhou R; Song N; Liu L; Qian J
Biomed Pharmacother; 2020 May; 125():110001. PubMed ID: 32070878
[TBL] [Abstract][Full Text] [Related]
18. Dexmedetomidine ameliorates renal ischemia reperfusion-mediated activation of the NLRP3 inflammasome in alveolar macrophages.
Chen Y; Huang Y; Xiong B; Luo H; Song X
Gene; 2020 Oct; 758():144973. PubMed ID: 32707303
[TBL] [Abstract][Full Text] [Related]
19. Dexmedetomidine alleviates myocardial ischemia/reperfusion-induced injury and Ca
Zheng X; Li J; Fan Q; Zhao X; Chen K
Int J Cardiol; 2021 Sep; 338():185-195. PubMed ID: 33731281
[TBL] [Abstract][Full Text] [Related]
20. Salidroside alleviates acetaminophen-induced hepatotoxicity via Sirt1-mediated activation of Akt/Nrf2 pathway and suppression of NF-κB/NLRP3 inflammasome axis.
Gao Z; Zhan H; Zong W; Sun M; Linghu L; Wang G; Meng F; Chen M
Life Sci; 2023 Aug; 327():121793. PubMed ID: 37224954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
